PRODUCTS

MegaFill®
MegaFill®
Definition

MegaFill® is produced after pulverizing MegaDerm®, and is composed of the same extracellular matrix components (collagens, elastin, proteins, and proteoglycans) as that of MegaDerm®.

Raw material
  •  Skin
Type
  •  MegaFill®
  •  MegaFill® UP
  •  MegaFill® Plus (Medical device for export I Approval No. 14-1217)
Features
  •  Excellent biocompatibility
  •  Particle-type acellular dermal matrix
  •  Outstanding retention

 
* Patent: Cross-linking and bio-graft of acellular dermis or the manufacturing method of implant compositions [NO. 10-1650273]

 

Indications
  •  Vocal Fold Paralysis
  •  Laryngoplasty
  •  Rhinoplasty
  •  Facial Reconstruction
  •  Breast Reconstruction
  •  Diabetic Foot Ulcer
  •  Facial Treatment
  •  Soft Tissue Reconstruction
Related Reference
  • Micronized Cross-Linked Human Acellular Dermal Matrices: An Effective Scaffold for Collagen Synthesis and Promising Material for Tissue Augmentation
    Tae Hwan Park et al. Tissue Eng Regen Med (2017) 14(5):517–523